We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current PLSE market cap is 415.19M. The company's latest EPS is USD -1.0639 and P/E is -8.15.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | -9k | 0 | 0 | 0 |
Operating Income | -18.03M | -8.75M | -9.56M | -10.23M | -11.25M |
Net Income | -18.04M | -9.2M | -9.8M | -9.91M | -10.57M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 1.42M | 700k |
Operating Income | -37.96M | -47.95M | -49.97M | -63.01M | -58.06M |
Net Income | -37.55M | -46.97M | -49.85M | -63.66M | -58.51M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 87.57M | 77.88M | 70.22M | 74.76M | 65.95M |
Total Liabilities | 81.38M | 80.13M | 80.89M | 14.26M | 13.8M |
Total Equity | 6.19M | -2.25M | -10.67M | 60.5M | 52.15M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 70.64M | 41.92M | 41.29M | 54.25M | 77.88M |
Total Liabilities | 4.31M | 11.18M | 18.4M | 18.56M | 80.13M |
Total Equity | 66.33M | 30.74M | 22.89M | 35.69M | -2.25M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -39.05M | -47.01M | -6.57M | -15.77M | -26.26M |
Investing | -360k | -401k | -39k | -55k | -78k |
Financing | 79.96M | 79.94M | -432k | 13.44M | 15.58M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -23.9M | -34.19M | -35.37M | -54.1M | -47.01M |
Investing | 26.12M | -10.1M | 10.04M | 7.56M | -401k |
Financing | 45.5M | 82k | 30.89M | 62.69M | 79.94M |
Market Cap | 415.19M |
Price to Earnings Ratio | -8.15 |
Price to Sales Ratio | 682.68 |
Price to Cash Ratio | 7.8 |
Price to Book Ratio | -212.09 |
Dividend Yield | - |
Shares Outstanding | 54.99M |
Average Volume (1 week) | 121.09k |
Average Volume (1 Month) | 146.97k |
52 Week Change | 164.71% |
52 Week High | 13.62 |
52 Week Low | 2.36 |
Spread (Intraday) | 0.13 (1.67%) |
Company Name | Pulse Biosciences Inc |
Address |
corporation trust center 1209 orange st wilmington, delaware 19801 |
Website | https://www.pulsebiosciences.com |
Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions